Teva Pharmaceutical Industries Limited (TEVA)
| Previous Close | 8.31 |
| Open | 8.40 |
| Bid | 8.39 x 1800 |
| Ask | 8.49 x 3100 |
| Day's Range | 8.19 - 8.52 |
| 52 Week Range | 7.23 - 11.55 |
| Volume | |
| Avg. Volume | 9,047,208 |
| Market Cap | 9.342B |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | 12.83 |
| EPS (TTM) | 0.66 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 27, 2017 |
| 1y Target Est | 11.36 |
- Reuters
UPDATE 3-Teva, Allergan reach $161.5 mln opioid settlement with West Virginia
Teva Pharmaceutical Industries and AbbVie's Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said on Wednesday. The agreement is the largest state-negotiated settlement in West Virginia history, and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses, Morrisey said at a news conference.
- Reuters
Teva, Allergan reach $161.5 million opioid settlement with West Virginia
(Reuters) -Teva Pharmaceutical Industries and AbbVie's Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said Wednesday. The agreement is the largest state-negotiated settlement in West Virginia history, and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses, Morrisey said. "This is a great day for West Virginia," Morrisey said at a press conference.
- Business Wire
Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims
TEL AVIV, Israel & PARSIPPANY, N.J., May 25, 2022--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and its affiliates, has reached an agreement with the Attorney General of West Virginia that settles the state’s and its subdivisions opioid-related claims. The settlement will provide West Virginia with $75 million over 15 years in addition to $8 million in attorneys’ fees and costs incurred during the trial. Teva will also provide its life-savin
